Tuberculosis and COVID-19 Dually Affect Human Th17 Cell Immune Response
Open Access
- 27 July 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (8) , 2123
Abstract
COVID-19 infection not only profoundly impacts the detection of tuberculosis infection (Tbc) but also affects modality in tuberculosis patient immune response. It is important to determine immune response alterations in latent tuberculosis infection as well as in SARS-CoV-2-infected tuberculosis patients. Such changes may have underlying effects on the development and course of further tuberculosis. Here, we aimed to review the characteristics of immune response in TB patients or convalescent COVID-19 patients with latent TB infection (LTBI). Materials and Methods. We analyzed the features of immune response in tuberculosis and COVID-19 patients. For this, we analyzed publications released from December 2019 to March 2023; those which were published in accessible international databases (“Medline”, “PubMed”, “Scopus”) and with keywords such as “COVID-19”, “SARS-CoV-2”, “tuberculosis”, “pulmonary tuberculosis”, “latent tuberculosis infection”, “Treg”, “follicular Treg”, and “Treg subsets”, we considered. Results. Through our analysis, we found that tuberculosis patients who had been infected with COVID-19 previously and elevated Th1 and Th2 cell levels. High levels of Th1 and Th2 cells may serve as a positive marker, characterizing activated immune response during TB infection. COVID-19 or post-COVID-19 subjects showed decreased Th17 levels, indicating a lack of tuberculosis development. Moreover, the typical course of tuberculosis is associated with an increase in Treg level, but COVID-19 contributes to a hyperinflammatory response. Conclusion. According to the data obtained, the course of tuberculosis proceeds in a dissimilar way due to the distinct immune response, elicited by SARS-CoV-2. Importantly, the development of active tuberculosis with a severe course is associated with a decline in Treg levels. Both pathogens lead to disturbed immune responses, increasing the risk of developing severe TB. The insights and findings of this paper may be used to improve the future management of individuals with latent and active tuberculosis.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (075-15-2022-301)
This publication has 114 references indexed in Scilit:
- CXCR5+ T helper cells mediate protective immunity against tuberculosisJournal of Clinical Investigation, 2013
- IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the diseaseJournal of Leukocyte Biology, 2012
- Role of the frequency of blood CD4+ CXCR5+ CCR6+ T cells in autoimmunity in patients with Sjögren’s syndromeBiochemical and Biophysical Research Communications, 2012
- Prognostic values of serum IP-10 and IL-17 in Patients with Pulmonary TuberculosisDisease Markers, 2011
- CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial CellsJournal of Virology, 2010
- Reduced Th17 Response in Patients with Tuberculosis Correlates with IL-6R Expression on CD4+ T CellsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Characterization of regulatory T cells identified as CD4+CD25highCD39+ in patients with active tuberculosisClinical and Experimental Immunology, 2009
- Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungsJournal of Experimental Medicine, 2007
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006